COVID-19 pneumonia in a child with hepatic encephalopathy: A case study
Iranian Journal of Child Neurology,
Vol. 15 No. 1 (2021),
1 January 2021
,
Page 113-118
https://doi.org/10.22037/ijcn.v15i1.30879
Abstract
Coronavirus disease 2019 (COVID-19) is caused by the seventh coronavirus, known as the severe acute respiratory syndrome coronavirus 2(SARS-CoV-2). Children often have milder diseases than adults with very rare mortality. Gastrointestinal manifestations and a mild increase in liver enzymes have been reported in 8.8% to 53% of COVID-19 cases. However, liver failure is extremely rare and has not been reported so far in the literature. The prevalence of comorbidities is not clear in children with COVID-19. Here, we reported a fatal case of simultaneous pneumonia secondary to SARS-CoV-2and acute liver failure in a 14-year-old boy with liver cirrhosis.
- COVID-19
- children
- pneumonia
- hepatic encephalopathy
- Chronic Liver Cirrhosis
How to Cite
References
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with
novel coronavirus in Wuhan, China. The lancet. 2020;395(10223):497-506.
Rismanbaf A, Zarei S. Liver and kidney injuries in COVID-19 and their effects on drug therapy;
a letter to editor. Arch Acad Emerg Med. 2020;8(1):e17.
Guan W-j, Ni Z-y, Hu Y, Liang W-h, Ou C-q, HeJ-x, et al. Clinical characteristics of coronavirus disease 2019 in China. New England journal of medicine. 2020;382(18):1708-20.
Ludvigsson JF. Systematic review of COVID‐19 in children shows milder cases and a better prognosis than adults. Acta Paediatrica. 2020;109(6):1088-95.
Zhao W, Zhong Z, Xie X, Yu Q, Liu J. Relation between chest CT findings and clinical conditions of coronavirus disease (COVID-19) pneumonia: a multicenter study. American Journal of Roentgenology. 2020;214(5):1072-7.
Singh S, Khan A. Clinical Characteristics and Outcomes of COVID-19 Among Patients with Pre-Existing Liver Disease in United States: A Multi-Center Research Network Study. Gastroenterology. 2020.
Chau TN, Lee KC, Yao H, Tsang TY, Chow TC, Yeung YC, et al. SARS‐associated viral hepatitis caused by a novel coronavirus: report of three cases. Hepatology. 2004;39(2):302-10.
Su T-H, Kao J-H. The clinical manifestations and management of COVID-19-related liver injury. Journal of the Formosan Medical Association. 2020.
Zhang C, Shi L, Wang F-S. Liver injury in COVID-19: management and challenges.
The lancet Gastroenterology & hepatology. 2020;5(5):428-30.
Boettler T, Newsome PN, Mondelli MU, Maticic M, Cordero E, Cornberg M, et al. Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper. JHEP Reports. 2020:100113.
- Abstract Viewed: 753 times